ALEX COURVILLE: Open Payments
NPI 1578983367 · KINDER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 47 payments from 16 companies in 2025. Trend: 2023 $652 · 2024 $1,316 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Exact Sciences Corporation | 2 | $35 |
| Indivior Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $27 |
Products named: VRAYLAR, CAPLYTA, Auvelity, UBRELVY, FANAPT, GEMTESA, Cologuard Collection Kit, SUBLOCADE.
Industry payments across LA — which companies pay providers there.
